Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Breast 1

Conditions

Uterine Neoplasms 1Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Desmoid Tumors 1Breast Neoplasms 1

Interventions

Imatinib Mesylate 3nirogacestat 2vactosertib 1strattice 1entinostat 1Vinblastine 1Toremifene 1Taxes 1Tamoxifen 1Surveys and Questionnaires 1Sunitinib 1Sulindac 1Sorafenib 1Sirolimus 1Radiotherapy 1Nivolumab 1Methotrexate 1Fentanyl 1Data Collection 1Cyclophosphamide 1Blood Specimen Collection 1Albumin-Bound Paclitaxel 1Abdominoplasty 14-hydroxy-N-desmethyltamoxifen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Desmoid Tumors × 4-hydroxy-N-desmethyltamoxifen × Clear all
NCT01273168 2025-12-23

Endoxifen in Adults With Hormone Receptor Positive Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
40 enrolled
BreastGynecologicSarcoma

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡